Impact of pharmacogenetics on aspirin resistance: a systematic review
Background Pharmacogenetics promises better control of diseases such as cardiovascular disease (CVD). Acetylsalicylic acid, aspirin, prevents the formation of an activating agent of platelet aggregation and vasoconstriction, and it is used to prevent CVD. Nevertheless, patients may have treatment fa...
Saved in:
| Main Authors: | Gustavo Figueiredo da Silva, Bruno Mattei Lopes, Vinicius Moser, Leslie Ecker Ferreira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2023-01-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1758445 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics polygenic response score predicts outcomes in aspirin-treated stroke patients
by: Rui-Nan Ma, et al.
Published: (2025-04-01) -
ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01) -
Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology
by: Luciana Maria Marangoni-Iglecias, et al.
Published: (2025-04-01) -
Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01) -
Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive review
by: Rania Magadmi
Published: (2025-12-01)